nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Ill-defined disorder—Dactinomycin—muscle cancer	0.00493	0.00493	CcSEcCtD
Carbidopa—Anaemia—Dactinomycin—muscle cancer	0.00491	0.00491	CcSEcCtD
Carbidopa—Dyskinesia—Doxorubicin—muscle cancer	0.00485	0.00485	CcSEcCtD
Carbidopa—Acute coronary syndrome—Etoposide—muscle cancer	0.00485	0.00485	CcSEcCtD
Carbidopa—Myocardial infarction—Etoposide—muscle cancer	0.00482	0.00482	CcSEcCtD
Carbidopa—Neuropathy peripheral—Etoposide—muscle cancer	0.00482	0.00482	CcSEcCtD
Carbidopa—Alopecia—Vincristine—muscle cancer	0.00481	0.00481	CcSEcCtD
Carbidopa—Malaise—Dactinomycin—muscle cancer	0.00479	0.00479	CcSEcCtD
Carbidopa—Mental disorder—Vincristine—muscle cancer	0.00477	0.00477	CcSEcCtD
Carbidopa—Leukopenia—Dactinomycin—muscle cancer	0.00475	0.00475	CcSEcCtD
Carbidopa—Gait disturbance—Doxorubicin—muscle cancer	0.00467	0.00467	CcSEcCtD
Carbidopa—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00461	0.00461	CcSEcCtD
Carbidopa—Agranulocytosis—Etoposide—muscle cancer	0.00459	0.00459	CcSEcCtD
Carbidopa—Back pain—Vincristine—muscle cancer	0.00459	0.00459	CcSEcCtD
Carbidopa—Hiccups—Doxorubicin—muscle cancer	0.00456	0.00456	CcSEcCtD
Carbidopa—Discomfort—Dactinomycin—muscle cancer	0.00447	0.00447	CcSEcCtD
Carbidopa—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00443	0.00443	CcSEcCtD
Carbidopa—Hypoaesthesia—Etoposide—muscle cancer	0.00439	0.00439	CcSEcCtD
Carbidopa—Anaemia—Vincristine—muscle cancer	0.00438	0.00438	CcSEcCtD
Carbidopa—Urinary tract disorder—Etoposide—muscle cancer	0.00436	0.00436	CcSEcCtD
Carbidopa—Agitation—Vincristine—muscle cancer	0.00436	0.00436	CcSEcCtD
Carbidopa—Oedema—Dactinomycin—muscle cancer	0.00433	0.00433	CcSEcCtD
Carbidopa—Urethral disorder—Etoposide—muscle cancer	0.00433	0.00433	CcSEcCtD
Carbidopa—Infection—Dactinomycin—muscle cancer	0.0043	0.0043	CcSEcCtD
Carbidopa—Blood urea increased—Doxorubicin—muscle cancer	0.0043	0.0043	CcSEcCtD
Carbidopa—Leukopenia—Vincristine—muscle cancer	0.00425	0.00425	CcSEcCtD
Carbidopa—Thrombocytopenia—Dactinomycin—muscle cancer	0.00424	0.00424	CcSEcCtD
Carbidopa—Anorexia—Dactinomycin—muscle cancer	0.00413	0.00413	CcSEcCtD
Carbidopa—Convulsion—Vincristine—muscle cancer	0.00411	0.00411	CcSEcCtD
Carbidopa—Flushing—Etoposide—muscle cancer	0.0041	0.0041	CcSEcCtD
Carbidopa—Hypertension—Vincristine—muscle cancer	0.00409	0.00409	CcSEcCtD
Carbidopa—Alopecia—Etoposide—muscle cancer	0.0039	0.0039	CcSEcCtD
Carbidopa—Oedema—Vincristine—muscle cancer	0.00387	0.00387	CcSEcCtD
Carbidopa—Infection—Vincristine—muscle cancer	0.00385	0.00385	CcSEcCtD
Carbidopa—Phlebitis—Doxorubicin—muscle cancer	0.00384	0.00384	CcSEcCtD
Carbidopa—Thrombocytopenia—Vincristine—muscle cancer	0.00379	0.00379	CcSEcCtD
Carbidopa—Decreased appetite—Dactinomycin—muscle cancer	0.00377	0.00377	CcSEcCtD
Carbidopa—Dysgeusia—Etoposide—muscle cancer	0.00376	0.00376	CcSEcCtD
Carbidopa—Hyperhidrosis—Vincristine—muscle cancer	0.00374	0.00374	CcSEcCtD
Carbidopa—Fatigue—Dactinomycin—muscle cancer	0.00374	0.00374	CcSEcCtD
Carbidopa—Back pain—Etoposide—muscle cancer	0.00372	0.00372	CcSEcCtD
Carbidopa—Pain—Dactinomycin—muscle cancer	0.0037	0.0037	CcSEcCtD
Carbidopa—Vascular purpura—Doxorubicin—muscle cancer	0.0037	0.0037	CcSEcCtD
Carbidopa—Muscle spasms—Etoposide—muscle cancer	0.00369	0.00369	CcSEcCtD
Carbidopa—Anorexia—Vincristine—muscle cancer	0.00369	0.00369	CcSEcCtD
Carbidopa—Hypotension—Vincristine—muscle cancer	0.00362	0.00362	CcSEcCtD
Carbidopa—Ataxia—Methotrexate—muscle cancer	0.00359	0.00359	CcSEcCtD
Carbidopa—Feeling abnormal—Dactinomycin—muscle cancer	0.00357	0.00357	CcSEcCtD
Carbidopa—Ill-defined disorder—Etoposide—muscle cancer	0.00356	0.00356	CcSEcCtD
Carbidopa—Anaemia—Etoposide—muscle cancer	0.00355	0.00355	CcSEcCtD
Carbidopa—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00354	0.00354	CcSEcCtD
Carbidopa—Hot flush—Doxorubicin—muscle cancer	0.00354	0.00354	CcSEcCtD
Carbidopa—Menopausal symptoms—Doxorubicin—muscle cancer	0.00351	0.00351	CcSEcCtD
Carbidopa—Insomnia—Vincristine—muscle cancer	0.0035	0.0035	CcSEcCtD
Carbidopa—Paraesthesia—Vincristine—muscle cancer	0.00348	0.00348	CcSEcCtD
Carbidopa—Malaise—Etoposide—muscle cancer	0.00346	0.00346	CcSEcCtD
Carbidopa—Dermatitis bullous—Doxorubicin—muscle cancer	0.00346	0.00346	CcSEcCtD
Carbidopa—Leukopenia—Etoposide—muscle cancer	0.00344	0.00344	CcSEcCtD
Carbidopa—Purpura—Doxorubicin—muscle cancer	0.00343	0.00343	CcSEcCtD
Carbidopa—Body temperature increased—Dactinomycin—muscle cancer	0.00342	0.00342	CcSEcCtD
Carbidopa—Abdominal pain—Dactinomycin—muscle cancer	0.00342	0.00342	CcSEcCtD
Carbidopa—Loss of consciousness—Etoposide—muscle cancer	0.00338	0.00338	CcSEcCtD
Carbidopa—Decreased appetite—Vincristine—muscle cancer	0.00336	0.00336	CcSEcCtD
Carbidopa—Cough—Etoposide—muscle cancer	0.00335	0.00335	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Vincristine—muscle cancer	0.00334	0.00334	CcSEcCtD
Carbidopa—Fatigue—Vincristine—muscle cancer	0.00334	0.00334	CcSEcCtD
Carbidopa—Convulsion—Etoposide—muscle cancer	0.00333	0.00333	CcSEcCtD
Carbidopa—Hyponatraemia—Doxorubicin—muscle cancer	0.00332	0.00332	CcSEcCtD
Carbidopa—Hypertension—Etoposide—muscle cancer	0.00332	0.00332	CcSEcCtD
Carbidopa—Pain—Vincristine—muscle cancer	0.00331	0.00331	CcSEcCtD
Carbidopa—Constipation—Vincristine—muscle cancer	0.00331	0.00331	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Carbidopa—Diplopia—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Carbidopa—Pain in extremity—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Carbidopa—Chest pain—Etoposide—muscle cancer	0.00327	0.00327	CcSEcCtD
Carbidopa—Discomfort—Etoposide—muscle cancer	0.00323	0.00323	CcSEcCtD
Carbidopa—Hypersensitivity—Dactinomycin—muscle cancer	0.00319	0.00319	CcSEcCtD
Carbidopa—Gastrointestinal pain—Vincristine—muscle cancer	0.00317	0.00317	CcSEcCtD
Carbidopa—Confusional state—Etoposide—muscle cancer	0.00316	0.00316	CcSEcCtD
Carbidopa—Infection—Etoposide—muscle cancer	0.00312	0.00312	CcSEcCtD
Carbidopa—Ataxia—Doxorubicin—muscle cancer	0.00311	0.00311	CcSEcCtD
Carbidopa—Asthenia—Dactinomycin—muscle cancer	0.00311	0.00311	CcSEcCtD
Carbidopa—Blood creatinine increased—Doxorubicin—muscle cancer	0.0031	0.0031	CcSEcCtD
Carbidopa—Thrombocytopenia—Etoposide—muscle cancer	0.00307	0.00307	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00307	0.00307	CcSEcCtD
Carbidopa—Abdominal pain—Vincristine—muscle cancer	0.00306	0.00306	CcSEcCtD
Carbidopa—Body temperature increased—Vincristine—muscle cancer	0.00306	0.00306	CcSEcCtD
Carbidopa—Hyperhidrosis—Etoposide—muscle cancer	0.00303	0.00303	CcSEcCtD
Carbidopa—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00302	0.00302	CcSEcCtD
Carbidopa—Anorexia—Etoposide—muscle cancer	0.00299	0.00299	CcSEcCtD
Carbidopa—Diarrhoea—Dactinomycin—muscle cancer	0.00296	0.00296	CcSEcCtD
Carbidopa—Nasopharyngitis—Doxorubicin—muscle cancer	0.00296	0.00296	CcSEcCtD
Carbidopa—Depression—Methotrexate—muscle cancer	0.00294	0.00294	CcSEcCtD
Carbidopa—Hypotension—Etoposide—muscle cancer	0.00293	0.00293	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—muscle cancer	0.00293	0.00293	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—muscle cancer	0.00286	0.00286	CcSEcCtD
Carbidopa—Hypersensitivity—Vincristine—muscle cancer	0.00285	0.00285	CcSEcCtD
Carbidopa—Paraesthesia—Etoposide—muscle cancer	0.00282	0.00282	CcSEcCtD
Carbidopa—Dyspnoea—Etoposide—muscle cancer	0.0028	0.0028	CcSEcCtD
Carbidopa—Somnolence—Etoposide—muscle cancer	0.00279	0.00279	CcSEcCtD
Carbidopa—Asthenia—Vincristine—muscle cancer	0.00278	0.00278	CcSEcCtD
Carbidopa—Vomiting—Dactinomycin—muscle cancer	0.00275	0.00275	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—muscle cancer	0.00275	0.00275	CcSEcCtD
Carbidopa—Rash—Dactinomycin—muscle cancer	0.00273	0.00273	CcSEcCtD
Carbidopa—Decreased appetite—Etoposide—muscle cancer	0.00273	0.00273	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Etoposide—muscle cancer	0.00271	0.00271	CcSEcCtD
Carbidopa—Fatigue—Etoposide—muscle cancer	0.0027	0.0027	CcSEcCtD
Carbidopa—Pain—Etoposide—muscle cancer	0.00268	0.00268	CcSEcCtD
Carbidopa—Constipation—Etoposide—muscle cancer	0.00268	0.00268	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00266	0.00266	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—muscle cancer	0.00266	0.00266	CcSEcCtD
Carbidopa—Diarrhoea—Vincristine—muscle cancer	0.00265	0.00265	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—muscle cancer	0.00264	0.00264	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—muscle cancer	0.00261	0.00261	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—muscle cancer	0.0026	0.0026	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—muscle cancer	0.00259	0.00259	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—muscle cancer	0.00259	0.00259	CcSEcCtD
Carbidopa—Feeling abnormal—Etoposide—muscle cancer	0.00258	0.00258	CcSEcCtD
Carbidopa—Nausea—Dactinomycin—muscle cancer	0.00257	0.00257	CcSEcCtD
Carbidopa—Gastrointestinal pain—Etoposide—muscle cancer	0.00256	0.00256	CcSEcCtD
Carbidopa—Dizziness—Vincristine—muscle cancer	0.00256	0.00256	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Carbidopa—Urticaria—Etoposide—muscle cancer	0.00249	0.00249	CcSEcCtD
Carbidopa—Abdominal pain—Etoposide—muscle cancer	0.00248	0.00248	CcSEcCtD
Carbidopa—Body temperature increased—Etoposide—muscle cancer	0.00248	0.00248	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—muscle cancer	0.00248	0.00248	CcSEcCtD
Carbidopa—Vomiting—Vincristine—muscle cancer	0.00246	0.00246	CcSEcCtD
Carbidopa—Rash—Vincristine—muscle cancer	0.00244	0.00244	CcSEcCtD
Carbidopa—Dermatitis—Vincristine—muscle cancer	0.00244	0.00244	CcSEcCtD
Carbidopa—Headache—Vincristine—muscle cancer	0.00242	0.00242	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—muscle cancer	0.00234	0.00234	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Carbidopa—Hypersensitivity—Etoposide—muscle cancer	0.00231	0.00231	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—muscle cancer	0.0023	0.0023	CcSEcCtD
Carbidopa—Nausea—Vincristine—muscle cancer	0.0023	0.0023	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—muscle cancer	0.00228	0.00228	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—muscle cancer	0.00225	0.00225	CcSEcCtD
Carbidopa—Asthenia—Etoposide—muscle cancer	0.00225	0.00225	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Carbidopa—Back pain—Methotrexate—muscle cancer	0.00223	0.00223	CcSEcCtD
Carbidopa—Pruritus—Etoposide—muscle cancer	0.00222	0.00222	CcSEcCtD
Carbidopa—Vision blurred—Methotrexate—muscle cancer	0.00217	0.00217	CcSEcCtD
Carbidopa—Diarrhoea—Etoposide—muscle cancer	0.00215	0.00215	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—muscle cancer	0.00213	0.00213	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Carbidopa—Malaise—Methotrexate—muscle cancer	0.00208	0.00208	CcSEcCtD
Carbidopa—Dizziness—Etoposide—muscle cancer	0.00207	0.00207	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Carbidopa—Cough—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—muscle cancer	0.00199	0.00199	CcSEcCtD
Carbidopa—Vomiting—Etoposide—muscle cancer	0.00199	0.00199	CcSEcCtD
Carbidopa—Rash—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Carbidopa—Dermatitis—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Carbidopa—Headache—Etoposide—muscle cancer	0.00196	0.00196	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Carbidopa—Tension—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—muscle cancer	0.00189	0.00189	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Carbidopa—Infection—Methotrexate—muscle cancer	0.00187	0.00187	CcSEcCtD
Carbidopa—Nausea—Etoposide—muscle cancer	0.00186	0.00186	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—muscle cancer	0.00184	0.00184	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Carbidopa—Hyperhidrosis—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—muscle cancer	0.00179	0.00179	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Carbidopa—Cough—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—muscle cancer	0.00173	0.00173	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—muscle cancer	0.00167	0.00167	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—muscle cancer	0.00167	0.00167	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—muscle cancer	0.00164	0.00164	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00162	0.00162	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—muscle cancer	0.00162	0.00162	CcSEcCtD
Carbidopa—Infection—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Carbidopa—Pain—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Carbidopa—Shock—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—muscle cancer	0.00155	0.00155	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—muscle cancer	0.00154	0.00154	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—muscle cancer	0.00149	0.00149	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Carbidopa—Pain—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—muscle cancer	0.00133	0.00133	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—muscle cancer	0.00129	0.00129	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Carbidopa—Rash—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Carbidopa—Headache—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Carbidopa—Nausea—Methotrexate—muscle cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Carbidopa—Rash—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Carbidopa—Headache—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—muscle cancer	0.000966	0.000966	CcSEcCtD
